HYALGAN INJECTION 20 mg/2 ml
Product details
Registration number: SIN06242P
Classification: Prescription Only
Active ingredients: SODIUM HYALURONATE
Strength: 20 mg/2 ml
Dosage form: INJECTION
Route: INTRA-ARTICULAR
Registrant: PHARMAFORTE SINGAPORE PTE LTD
ATC code: S01KA01
HSA approval date: 22 June 1991
Manufacturer(s): FIDIA FARMACEUTICI S.P.A
Manufacturing country/countries: ITALY
What are the HSA registration number and classification for HYALGAN INJECTION 20 mg/2 ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN06242P
Classification: Prescription Only
What active ingredients and strength are recorded for HYALGAN INJECTION 20 mg/2 ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: SODIUM HYALURONATE
Strength: 20 mg/2 ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for HYALGAN INJECTION 20 mg/2 ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: INTRA-ARTICULAR
Who is the recorded registrant for HYALGAN INJECTION 20 mg/2 ml?
According to the HSA dataset updated 7 August 2026:
Registrant: PHARMAFORTE SINGAPORE PTE LTD
Which manufacturers and countries are listed for HYALGAN INJECTION 20 mg/2 ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): FIDIA FARMACEUTICI S.P.A
Manufacturing country/countries: ITALY
Where can I look up HYALGAN INJECTION 20 mg/2 ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN06242P or the exact product name HYALGAN INJECTION 20 mg/2 ml. The general register link does not preselect this product.
What are the source dates for this HYALGAN INJECTION 20 mg/2 ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this HYALGAN INJECTION 20 mg/2 ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN06242P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)